Clinical Trials Logo

Arthritis clinical trials

View clinical trials related to Arthritis.

Filter by:

NCT ID: NCT00527189 Completed - Arthritis Clinical Trials

Balance Impairment and Falls Risk in People With Lower Limb Arthritis, and Can These be Improved With Exercise?

Start date: January 2006
Phase: N/A
Study type: Interventional

Arthritis has been reported as a risk factor for falls. Few studies have investigated the effect of balance training on balance performance in women with lower limb arthritis. The aim of this study was to evaluate the effectiveness of a four-month individualised home exercise programme in improving gait stability and balance for women with arthritis.

NCT ID: NCT00526435 Completed - Arthritis Clinical Trials

Evaluation of Walk With Ease in Arthritis

WWE
Start date: October 2007
Phase: Phase 3
Study type: Interventional

The overall goal of this study is to determine the whether the Walk with Ease (WWE) program in its 2 version (group-assisted and self-directed) can increase physical activity and fitness levels among individuals (18 years and older) with arthritis over the long-term. Participants will be approximately 657 subjects from 20-24 rural and urban communities across North Carolina. It is expected that participants in the WWE program will have reduced pain, improved function and increased activity levels after participation in this 6-week program.

NCT ID: NCT00526201 Completed - Arthritis Clinical Trials

Help Arthritis With Exercise in West Virginia

HARE
Start date: May 2009
Phase: Phase 3
Study type: Interventional

The purpose of this project is to determine if an evidence-based, community-delivered physical activity program, EnhanceFitness, yields benefits for participants with arthritis. The 3-year project will: 1) conduct a meta-analysis of community-based exercise programs for adults, 2) implement and evaluate the EnhanceFitness program in West Virginia using a randomized, controlled (wait list) design, and 3) disseminate the results to community and public health partners. It is anticipated that participation in the EnhanceFitness program will result in reduced pain, improved physical function and physical activity levels for adults with arthritis.

NCT ID: NCT00524160 Completed - Clinical trials for Rheumatoid Arthritis

A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis

Start date: July 2001
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the degree of pain control achieved by treatment with fentanyl, administered via adhesive patches applied to the skin ('transdermal system") in patients with rheumatoid arthritis or osteoarthritis of the knee or hip. Treatment will be administered fo r4 weeks, added on to existing therapy with other medications.

NCT ID: NCT00522184 Completed - Clinical trials for Rheumatoid Arthritis

Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study

Start date: February 2005
Phase: Phase 3
Study type: Interventional

Intra-articular injection of etanercept in patient suffering from rheumatoid arthritis: a double-blind randomized study for evaluation of efficacy and safety of etanercept versus intra-articular steroid injection in acute synovitis (knee,wrist,ankle,elbow)

NCT ID: NCT00522054 Completed - Clinical trials for Rheumatoid Arthritis

Tai Chi for Patients With Rheumatoid Arthritis

Start date: September 2004
Phase: N/A
Study type: Interventional

The purpose of this study was to study the impact of Tai Chi group exercise on physical function, health and disease activity of patients with RA, and to examine the patients' experience and perception of Tai Chi.

NCT ID: NCT00522002 Completed - Clinical trials for Rheumatoid Arthritis

CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study

CLUE
Start date: August 2007
Phase: N/A
Study type: Observational

To explore the hypothesis that leg ulcers are associated with hypercoagulable states, the CLUE study will evaluate patients with connective tissue disease associated leg ulcers, to identify risk factors (especially hypercoagulability and immunologic characteristics), characterize pathogenesis, predict response to therapy, and assess the impact of lower extremity ulcers on quality of life.

NCT ID: NCT00520572 Completed - Clinical trials for Rheumatoid Arthritis

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

Start date: August 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to confirm that AZD9056 is effective in treating rheumatoid arthritis with regard to signs and symptoms and to determine what dose is favourable over a 6-month treatment period. Patients will receive background treatment with either Methotrexate or Sulphasalazine

NCT ID: NCT00513591 Completed - Clinical trials for Rheumatoid Arthritis

Duke Autoimmunity in Pregnancy Registry

DAP Registry
Start date: August 2007
Phase:
Study type: Observational

It is difficult to predict how a women with an autoimmune disease will do during pregnancy. Some women will improve, others will worsen. Some pregnancies progress normally and others become very complicated. The Duke Autoimmunity in Pregnancy (DAP) Registry will enroll women with autoimmune diseases, such as lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome who wish to become, or already are, pregnant. We will follow these women throughout pregnancy to better understand how their autoimmune disease affects their pregnancy, and vice versa.

NCT ID: NCT00510536 Completed - Arthritis Clinical Trials

Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab

Start date: July 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate tolerability and effectiveness of conventional treatment for mild to moderate arthritic or arthralgic symptoms while subjects are being treated with efalizumab for psoriasis.